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Abstract
Background: The Subacromial Impingement Syndrome (SIS) is the most common diagnosed disorder of the
shoulder in primary health care, but its aetiology is unclear. Conservative treatment regimes focus at reduction of
subacromial inflammatory reactions or pathologic scapulohumeral motion patterns (intrinsic aetiology). Long-lasting
symptoms are often treated with surgery, which is focused at enlarging the subacromial space by resection of the
anterior part of the acromion (based on extrinsic aetiology). Despite that acromionplasty is in the top-10 of
orthopaedic surgical procedures, there is no consensus on its indications and reported results are variable
(successful in 48-90%). We hypothesize that the aetiology of SIS, i.e. an increase in subacromial pressure or
decrease of subacromial space, is multi-factorial. SIS can be the consequence of pathologic scapulohumeral motion
patterns leading to humerus cranialisation, anatomical variations of the scapula and the humerus (e.g. hooked
acromion), a subacromial inflammatory reaction (e.g. due to overuse or micro-trauma), or adjoining pathology (e.g.
osteoarthritis in the acromion-clavicular-joint with subacromial osteophytes).
We believe patients should be treated according to their predominant etiological mechanism(s). Therefore, the
objective of our study is to identify and discriminate etiological mechanisms occurring in SIS patients, in order to
develop tailored diagnostic and therapeutic strategies.
Methods: In this cross-sectional descriptive study, applied clinical and experimental methods to identify intrinsic
and extrinsic etiologic mechanisms comprise: MRI-arthrography (eligibility criteria, cuff status, 3D-segmented bony
contours); 3D-motion tracking (scapulohumeral rhythm, arm range of motion, dynamic subacromial volume
assessment by combining the 3D bony contours and 3D-kinematics); EMG (adductor co-activation) and
dynamometry instrumented shoulder radiographs during arm tasks (force and muscle activation controlled
acromiohumeral translation assessments); Clinical phenotyping (Constant Score, DASH, WORC, and SF-36 scores).
Discussion: By relating anatomic properties, kinematics and muscle dynamics to subacromial volume, we expect
to identify one or more predominant pathophysiological mechanisms in every SIS patient. These differences in
underlying mechanisms are a reflection of the variations in symptoms, clinical scores and outcomes reported in
literature. More insight in these mechanisms is necessary in order to optimize future diagnostic and treatment
strategies for patients with SIS symptoms.
Trial registration: Dutch Trial Registry (Nederlands Trial Register) NTR2283.
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Introduction
The Subacromial Impingement Syndrome (SIS) can be
defined as symptomatic irritation of the rotator cuff and
subacromial bursa in the limited subacromial space.
Clinical characteristics are pain with arm abduction
(painful arc), decreased active range of motion (RoM)
and loss of arm force and function [1-5]. It is the most
frequently diagnosed shou l d e rd i s o r d e ri np r i m a r y
health care, accounting for 44-65% of all shoulder com-
plaints [3,6]. Symptoms can persist for months or years
and the majority of patients are between 40 and 50
years old. Consequently, SIS has a significant socioeco-
nomic impact [7].
Despite its reported prevalence, the diagnostic criteria
and aetiology of SIS are debatable. Two main etiologic the-
ories have been described. Neer’s widely accepted impin-
gement theory focuses on the extrinsic mechanism:
symptoms result from compressive forces on the rotator
cuff, caused by biomechanical or structural anatomic
(bony) abnormalities [8,9]. The mechanisms leading to
this assumed compression remain unclear. Scapula dyski-
nesia, causing relative cranial translation of the humerus,
has been reported [6,10-13]. Other studies describe a cor-
relation between SIS and acromial shape (hooked acro-
mion, Bigliani classification [14] type II or III) [4,15-18].
Presumably, this hooked acromion is a pre-existing ana-
tomic variation or a traction spur on the coracoacromial
ligament caused by repetitive cranially directed transla-
tions of the humerus or by tendinopathy. Others conclude
there is no relation between acromial shape and SIS, or
underline the difficulties in using acromial shape as an
assessment tool [16,19,20]. The majority of partial rotator
cuff tears, commonly referred to as a consequence or
entity of SIS, are often either intratendinous or at the
articular side of the rotator cuff and not at the bursal side
where they would be expected if the rotator cuff ‘impinges’
against a hooked acromion [21]. Despite these unclarities,
the extrinsic mechanism forms the rationale for one of the
most frequently performed orthopaedic surgical proce-
dures: acromionplasty. The second theory is based on a
degenerative intrinsic mechanism: SIS can be caused by
ischemia at the watershed zone of the supraspinatus ten-
don. This is enhanced by micro traumata or overuse, ten-
sile overload on degenerating rotator cuff tendons, a
subacromial inflammatory reaction, or insufficient cuff
function leading to an imbalance between glenohumeral
mobility and joint stability, with consequent glenohumeral
destabilization or altered arm-shoulder kinematics [22-29].
Thirdly, SIS can be the consequence of adjoining patholo-
gies or joint hyperlaxity. Furthermore, less classic forms of
shoulder impingement, e.g. internal impingement and cor-
acoid impingement have been described.
Treatment of SIS generally starts with conservative
methods, including arm rest or physical therapy, non-
steroidal anti-inflammatory drugs (NSAIDs) and subacro-
mial corticosteroids injections. Conservative therapy is
successful in 42% (Bigliani type III) to 91% (Bigliani type I)
[30,31]. When conservative treatments fail, the classic sur-
gical treatment of primary SIS is an acromionplasty as
described by Neer [8,9]. Variable and often mediocre
results of this frequently applied procedure have been
reported, with success rates ranging from 48 to 90%
[32-36]. However, acromionplasty doesn’t affect continu-
ing degeneration of the rotator cuff [37], and subacromial
spur recurrence has been reported following acromion-
plasty [21,38,39]. Henkus et al. reported comparable
results for acromionplasty and bursectomy in patients
with SIS [40]. This is in concordance with other studies
that also report clinical improvements in SIS-patients
without changing the coracoacromial shape [31,40-44].
Although SIS has been typically assumed to be the result
of rotator cuff injury, the subacromial space is a complex
anatomical environment, containing several structures
that can be a source of pain. Even several pathologies that
have a similar patients’ history, pain patterns and findings
with physical examination, can be (mistakenly) diagnosed
as SIS [45]. In a recent study at our institution, 14 of 80
patients (17.5%) clinically diagnosed with SIS, had to be
excluded following MRI arthrography because of alterna-
tive shoulder pathology [40].
Concluding, the ongoing debate on the aetiology of
SIS, its varying clinical presentations, the diagnostic dif-
ficulties and the highly variable treatment outcomes of
SIS suggest there might be multiple pathophysiologic
mechanisms leading to complaints clinically diagnosed
as SIS that need specific approaches in clinical practice.
Hypothesis
The extrinsic pathophysiologic mechanism is only valid
for a subgroup of SIS patients, and consequently acro-
mionplasty is the wrong treatment for at least a part of
the patients suffering from SIS symptoms. The com-
plaints observed in SIS are presumably a compilation of
symptoms that originate from different shoulder pathol-
ogies and etiologic mechanisms. It is our challenge to
discriminate these intrinsic and/or extrinsic underlying
aetiologies.
We developed a theoretical framework for the aetiol-
ogy of impingement ("a disbalance between subacromial
volume and the space needed for subacromial struc-
tures”, i.e. increased subacromial pressure) based on 4
distinct proposed mechanisms (Figure 1):
1) A dynamically reduced subacromial space due to a
pathologic pattern of arm-shoulder movements (e.g.
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of the humerus with respect to the scapula/acromion.
2) A more statically reduced subacromial space, due
to:
a. structural anatomic variations (e.g. a hooked
acromion), eventually in combination with
altered arm-scapula motion patterns;
b. a subacromial inflammatory reaction (e.g.
caused by micro-trauma or overuse) causing sub-
acromial oedema, fibrosis and tendinosis;
c. Encroachment of subacromial tissues by an
adjoining pathology or structures other than the
acromion (e.g. acromioclavicular (AC)-joint
osteoarthritis and subacromial osteophytes, calci-
fying tendinitis, and coracoid impingement).
In this study, factors associated with these SIS
mechanisms will be analyzed in patients clinically diag-
nosed with SIS. As a result, SIS patients will be cate-
gorised in “dynamic” and “static” etiologic subgroups,
each requiring tailored diagnostics and treatment
strategies.
Because subacromial impingement syndrome is a clini-
cal diagnosis, possible other causes of shoulder pain and
SIS symptoms (e.g. early stage frozen shoulder, calcifying
tendinitis, slap lesions, rotator cuff tears, etc.) are identi-
fied and, if eligible, analyzed separately in distinct
research projects (trial registry numbers: NTR1545 and
NTR2282).
Study goals
Primary goal
Identification and classification of distinct pathophysio-
logical mechanisms for symptoms clinically diagnosed as
SIS into identifiable subgroups of patients as categorized
above, in order to design tailored concept diagnostics
and treatment flowcharts from experimental concepts.
Secondary goals
A set of experimental and diagnostic tools is combined
to identify structural and biomechanical etiological
Figure 1 A. Schematic anatomy of a healthy glenohumeral joint and subacromial space. B. Schematic anatomy of a shoulder joint with the
presence of several etiologic mechanisms for Subacromial Impingement Syndrome. In theory, impingement ("a disbalance between acromial
space and the space needed for subacromial structures”) can be caused by 1) A dynamically reduced subacromial space due to a pathologic pattern
of arm-shoulder movements (e.g. scapular dyskinesia), resulting in relative cranialisation of the humerus with respect to the scapula/acromion, or2 )A
more statically reduced subacromial space, due to 2a) structural anatomic variations (e.g. a hooked acromion), eventually in combination with altered
arm-scapula motion patterns; 2b) A subacromial inflammatory reaction (e.g. caused by micro-trauma or overuse) causing subacromial oedema, fibrosis
and tendinosis; 2c) Encroachment of subacromial tissues by an adjoining pathology or structures other than the acromion (e.g. acromioclavicular (AC)-
joint osteoarthritis and subacromial osteophytes, calcifying tendinitis, and coracoid impingement).
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and functional status:
A. Presence and severity of pathologies in the subacro-
mial space with MRI, e.g. (partial) cuff-ruptures, tendi-
nosis, fibrosis or a subacromial inflammatory reaction,
and assessment of cuff degradation status.
B. Acromial shape classification and 3D shape para-
meters of the humerus, scapula and subacromial space
volume, using conventional radiographs and segmented
MRI-arthrographies.
C. Quantification of cranialisation of the humerus with
r e s p e c tt ot h es c a p u l aa tr e s ta n dd u r i n ga c t i v ea r m
abduction and adduction tasks with simultaneously
acquired shoulder radiographs and Electromyography
(EMG) recordings (see D).
D. Measurements of the activation of arm adductors
during arm abduction tasks and assessment of the pre-
sence of arm adductor co-activation (Activation Ratio).
E. Analyses of 3D-kinematics (arm range of motion
and scapulohumeral rhythm) of the affected SIS
shoulder compared to the unaffected shoulder and even-
tual etiologic SIS subgroups, with the use of 3D motion
registration.
F. Changes in reconstructed subacromial volume and
acromiohumeral distance during arm abduction by com-
bining the recorded 3D-kinematics with the MRI-seg-
mented 3D bony shapes.
G. The effect of a subacromial infiltration of lidocaïne
on arm range of motion, scapulohumeral and -thoracic
rhythm with arm abduction, reconstructed subacromial
volume and muscle activation patterns, including adduc-
tor co-activation.
H. Biomechanical analyses of structural or coordina-
tive muscular imbalance by means of model simulation
(Delft Shoulder and Elbow Model) with recorded
3D-kinematics as input.
I. Clinical phenotyping, using validated clinical scores
and questionnaires.
J. Identification of alternative diagnoses that may
cause complaints clinically diagnosed as SIS, using MRI
and radiographs (e.g. acromioclavicular-osteoarthritis
and subacromial osteophytes, calcifying tendinitis, SLAP
lesion or coracoid impingement).
Methods
Study design
In this multicentre observational cohort study, patients
clinically diagnosed with subacromial impingement syn-
drome in either one of 3 participating hospitals (Leiden
University Medical Centre (LUMC), Medical Centre
Haaglanden (MCH), Rijnland Hospital Leiderdorp) will
be included for analyses at the LUMC Laboratory for
Kinematics and Neuromechanics.
The Medical Ethics Committee of the university medi-
cal centre approved all stages of the study. Written
informed consent will be obtained from all patients.
Study population
Selection of participants
Patients will be recruited by 3 orthopaedic surgeons
involved in the 3 participating hospitals. Patients will be
selected if one or more of the following (limited) usual
care criteria are present, next to a positive Neer impin-
gement test (lidocaine) and a positive Hawkins test:
Patients’ history:
◦ diffuse unilateral shoulder pain for > 3 months;
◦ pain during activities with abduction, retroflexion
and/or internal rotation (e.g. closing the door, put-
ting on jacket, overhead activities);
◦ pain at night or incapable of lying on the shoulder.
Physical examination:
◦ positive Yocum test;
◦ painful arc;
◦ diffuse pain at palpation of the greater tuberosity;
◦ disturbed scapulohumeral rhythm;
◦ no signs of pathologies or symptoms on the con-
trolateral shoulder;
◦ capable of 90 degrees of passive abduction and
90 degrees of external rotation.
After the first and clinical inclusion round, symptoms
of eligible patients are further investigated with the use
of standard shoulder radiographs (anteroposterior in
both external and internal rotation and Y scapular view
(scapular outlet view)) and an MRI-arthrography of the
shoulder. The MRI-arthrographies are evaluated at the
local hospital for clinical purposes and additionally eval-
uated by one of two participating musculoskeletal radi-
ologists at LUMC for eligibility criteria and assessment
of acromion classification and rotator cuff status.
Patients are excluded if one of the following character-
istics is found with the visit to the outpatient clinic,
standard shoulder radiographs or MRI-arthrography:
◦ Age below 35 years or above 60 years;
◦ Restrictions in passive movements of the gleno-
humeral joint (adhesive capsulitis);
◦ History of fracture or dislocation of the shoulder,
history of surgery around the shoulder;
◦ Co-morbidities on the affected shoulder (includ-
ing fractures, benign or malignant tumours, labrum
abnormalities, Hill Sachs lesion, capsular or liga-
mentous abnormalities, glenohumeral instability,
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or symptomatic acromioclavicular osteoarthritis,
rheumatic disorder, biceps muscle tendinitis, com-
plete (full thickness) rotator cuff rupture, cervical
radiculopathy, PASTA lesion, Pulley lesion, calcify-
ing tendinitis > 3 mm, or neurological deficits);
◦ Symptoms on the controlateral shoulder;
◦ No informed consent.
Patients with either rotator cuff tears or calcifying ten-
dinitis are included, if eligible, in separate research
projects.
Sample size
A combination of techniques will be applied to classify
SIS-patients into pathophysiologic subgroups, most of
which are newly developed (section 2.3). The acromio-
humeral distance (AH) is a recognized parameter related
to rotator cuff disease and based on literature it has
rather wide inter-individual variations. Therefore, sam-
ple size calculation will be based on this parameter.
In a study of Gruber et al., AH values of 9.4 (SD =
3.4) were observed in subjects without diagnosed cuff
pathology. A subacromial space narrower than 6 mm on
radiographs is considered pathologic and strongly indi-
cative for supraspinatus tendon rupture [46].
The unpaired t-test was used to determine the sample
size with a difference of AH of 3.4 mm between groups
assumed as clinically relevant, comparing AH during
abduction task radiographs in patients where humerus
cranialisation plays a key-role compared to AH in other
subgroups of SIS patients.
Based on the standardized difference: 3.4 mm/3.4 mm
= 1.0, a required power of 80% and a p-value of 0.05 for
significance, the Altman’s Nomogram resulted in 30
shoulders/patients per group.
In our hypothesis, we defined 4 etiological mechan-
isms. Based on clinical experience and literature, we
assume around 30% type III acromion responsible for
complaints of SIS,[16] 20-30% of the SIS symptoms are
caused by humerus cranialisation and pathologic motion
patterns,[47] 15-20% by subacromial inflammatory pro-
cesses without subacromial narrowing and 5-10% by
other impinging structures than the acromion, leaving
around 10-30% for a group in which SIS symptoms
seem to be caused by two or more hypothesized etiolo-
gic mechanisms. With 30 patients needed in the
humerus cranialisation subgroup (i.e. 30% of the
patients), this leads to a total group size of 100 patients
diagnosed with SIS based on patient history, physical
examination, radiographs and MRI arthrography.
Additionally, we expect that around at least 25
patients will be diagnosed with another diagnosis than
SIS after MRI-arthrography and radiographs [40,48].
These patients can not be included in the SISTIM study
but selected patients will be analyzed separately in dis-
tinct research projects, if eligible (trial registry numbers:
NTR1545 and NTR2282).
Outcome measures
The included SIS-patients will be subjected to several
diagnostic and experimental tests at the LUMC depart-
ment of radiology (standard and force task radiographs
with EMG, MRI-arthrography) and the Laboratory for
Kinematics and Neuromechanics (shoulder kinematics,
EMG). The set of measurements is described below and
outcome parameters are defined, referring to the
mechanisms as summarized in out hypothesis and the
primary and secondary study goals (A to J).
Basic MRI outcomes (study goals A and J)
For the purpose of assessing eligibility criteria and alter-
native causes of impingement symptoms, an MRI-
arthrography is acquired in each patient. MRI’sa r e
reviewed by one of two participating musculoskeletal
radiologists at LUMC for inclusion and exclusion cri-
teria and standard clinical evaluation. Additionally, MRI
scans will be used to identify potential anatomic/struc-
tural causes for SIS symptoms and to assess rotator cuff
status (muscle volume, presence of tendinosis/tendinitis,
intratendinous, bursal or articular side partial tendon
tear, Goutallier score for muscle degeneration) [49,50].
Main outcome parameters: inclusion/exclusion of
patients, alternative diagnoses leading to SIS symptoms,
rotator cuff status, signs of anatomical or structural
causes for SIS symptoms.
2D radiographical analyses and EMG (B, C, D, J)
Standard anteroposterior shoulder radiographs enable
classification of the acromion shape. Patients’ acromion
Bigliani classification will be assessed: type I (flat), II
(curved) or III (hooked) [14]. We expect an incidence of
30% hooked acromions (type III) in SIS-patients [15].
Increased subacromial narrowing during arm abduc-
tion has been reported in patients with rotator cuff
degradation as a consequence of increased Deltoid mus-
cle activation [27,51-54]. In order to observe and study
this potential etiological mechanism, radiographs will be
acquired in rest position and during EMG-recorded iso-
metric arm abduction and adduction moment tasks of
equal force magnitude, using a set-up with a force sensor
and visual feedback (Figure 2). We will quantify the suba-
cromial space using the acromiohumeral distance mea-
sure (AH), upward migration index (UMI; similar to AH,
but corrected for image magnification and patients bony
morphological aspects) [55] and spinohumeral centre
method (SHC) [56]. Co-activation of medio-caudally
directed adductors during active arm abduction has been
reported to reduce this humerus cranialisation and con-
sequent pain in rotator cuff patients [5,51,57-60]. There-
fore, muscle activation will be controlled for during the
de Witte et al. BMC Musculoskeletal Disorders 2011, 12:282
http://www.biomedcentral.com/1471-2474/12/282
Page 5 of 12three tasks by simultaneous EMG recording with bi-polar
surface EMG of the main arm abductor (Deltoids) and
adductors (Latissimus Dorsi, Teres Major, Pectoralis
Major).
The relative activity of the glenohumeral abductors
and adductors will be quantified using the “Activation
Ratio” [58-60]. The Activation Ratio (ARmuscle) of each
muscle is determined according to its specific primary
function. Muscle activation is either ‘in-phase’ (A
IP)o r
‘out-of-phase’ (A
OP) with respect to its primary moment
arm. For example, activation of the medial part of the
Deltoid (ADM) is defined as ‘in phase’ during active arm
abduction tasks and as ‘out-of-phase’ during arm adduc-
tion tasks. Correspondingly, two average EMG levels are
determined for each muscle for ‘in phase’ and ‘out-of-
phase’ activation with respect to the isometric adduction
and abduction moment tasks. Based on these data, sub-
ject specific Activation Ratios can be calculated for each
muscle (ARmuscle), Eq 1:
ARmuscle =
AIP
muscle − AOP
muscle
AIP
muscle + AOP
muscle
[− 1 ≤ ARmuscle ≤ 1]
Consequently, AR’s of muscles in healthy subjects are
positive and close to 1. In subjects with co-activation of
arm adductors during abduction tasks, as has been
described for the Latissimus Dorsi and the Teres Major
in cuff tear patients, AR’s of arm adductor muscles are
closer to 0 or even negative. Therefore, we expect to
find low adductor Activation Ratios in at least a sub-
group of SIS patients, in response to reduced AH.
Main outcome parameters: Bigliani acromion classifica-
tion; Acromiohumeral distance (AH) in rest and during
abduction and adduction tasks; muscle-specific EMG Acti-
vation Ratios (ARdeltoid,A R lattisimus dorsi,A R teres mj,A R pectora-
lis mj) for quantification of (adductor) coactivation.
3D radiological analyses (B, F)
Aside from clinical purposes and evaluating inclusion
and exclusion criteria, MRI-arthrographies are also
acquired to obtain 3D shape parameters of the humerus,
scapula and subacromial space with the use of MRI seg-
mentation techniques (Amira 5.3, Visage Imaging Inc.,
San Diego, CA, USA).
Main 3D radiological outcome parameters:3 Ds h a p e
parameters for humerus, scapula and subacromial space.
3D kinematics and changes in subacromial volume (E, F, G)
Range of Motion (RoM) and 3D motions of forearm,
humerus and scapula with respect to the thorax will be
recorded by means of an electromagnetic tracking system:
‘Flock of Birds’ (FoB, Ascension Technology Corp, Bur-
lington, VT, USA) and custom made computer software
(FOBVis, Clinical Graphics, Delft, the Netherlands). The
FoB obtains 3D kinematical data using sensors on thorax,
scapula, humerus, forearm and thorax. After palpatory
identifying three dimensional positions of standard bony
landmarks of the arm, shoulder and thorax with respect to
the sensors for each patient, local bone coordinate systems
are created, based on the subject’s individual anatomy.
The glenohumeral rotation centre is estimated from the
position of five scapular bony landmarks using linear
regression [61]. The RoM of the following movements is
measured: anteflexion, retroflexion, abduction in frontal
plane, internal rotation in 0 and 90 degrees of arm abduc-
tion and external rotation in 0 and 90° of arm abduction.
3D kinematics and MRI bony segmentation (3D shape
parameters of scapula and humerus) will be combined in
custom made computer software (Articulus, Clinical Gra-
phics, Delft, the Netherlands) to reconstruct the subacro-
mial space volume and AH during recorded humerus
elevations, allowing dynamic measurements of patient-
specific subacromial space characteristics [5,62,63]. Addi-
tionally, the effect of a subacromial lidocaïne injection on
RoM, scapulohumeral rhythm, reconstructed AH and
Figure 2 Set-up for EMG-recorded isometric abduction and
adduction force tasks. Subjects are positioned in front of the
radiographic plate, in standing position with the concerning arm in
external rotation at his/her side (i.e. hand in frontal plane), enabling
the use of this set-up during concomitant acquirement of standard
shoulder radiographs. The arm is attached to a 1-dimensional force
transducer at the wrist, enabling subject specific force tasks, visual
feedback, and equal task force magnitude for abduction and
adduction tasks.
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analyzed.
Main kinematic outcome parameters: Passive and
active RoM during standardized arm motions (with and
without subacromial anaesthetics) of both arms; Scapu-
lohumeral rhythm of affected and healthy arm; Recon-
structed changes in AH and subacromial volume during
dynamic arm abduction (combining MRI-based shape
parameters and 3D RoM measurements).
EMG muscle activation patterns (C, D, G)
We will analyze muscle activation patterns as measured
by EMG recordings of 10 shoulder muscles, based on
Activation Ratio [58,59] and Principal Action parameters
[22,51]. Measurements will be performed before and
after a subacromial infiltration of lidocaïne (5 ml, 10
mg/ml), to study potential relations between pain during
arm abduction and adductor muscle co-activation and
arm-scapula kinematics, respectively.
Subjects are seated with the affected arm in a splint
with the upper arm in 45° of internal rotation and the
elbow in 90° of flexion. The humerus is positioned in
60° of forward elevation and in 30° of external rotation
relative to the transverse plane, Figure 3. The splint is
attached to a 3D force transducer which is mounted on
a sled so that it can move freely in a direction parallel
to the humeral longitudinal axis. The arm is fully sup-
ported in order to compensate for gravity. Axial rotation
of the humerus is mechanically not restricted to prevent
the subjects from generating supplementary moments.
In this way, patients can only exert forces perpendicular
to the longitudinal axis of the humerus.
The subjects are asked to exert a maximal voluntary
force (MVF) in 4 equidistant directions with a maxi-
mum of 50 N and maintain this force for 2 s using cus-
tom made visual feedback software (Matlab, The
MathWorks Inc, Natick, MA, USA). The exerted force
and force targets are visualized on a display, expressed
in cursor that has to be moved to consecutive targets on
a wheel in which the spokes denote force directions and
the rim denotes the desired force magnitude (Figure 3).
Subjects are subsequently asked to exert 75% of the low-
est MVF value onto the force transducer for 2 s in each
of 24 equidistant directions that are indicated on the
display. The same routine of 24 measurements will be
performed 30 min after a subacromial injection with
lidocaïne. Muscle activations for 10 muscles around the
shoulder are recorded in each of the 24 directions dur-
ing the 2 sets of measurements.
The direction of maximum activity or Principal Action
(PA) for each muscle is determined [22,51] and the
Activation Ratio of the abductor and adductor muscles
similar to the method described above [58,59]. We
expect that pain will influence the Principal Action
direction of the muscles [51]. Patients with pain will
consequently show an increase in activation of the gle-
nohumeral depressors during arm abduction moments
(i.e. adductor co-activation as expressed in low Activa-
tion Ratio’s). The AR’s obtained within this ‘Principal
Action’ set-up will be compared to AR’s obtained from
the derived abduction and adduction tasks as obtained
with the EMG set-up applied during the acquirement of
radiographs, taking potential experimental dependencies
of AR into account.
The second hypothesis is that after lidocaine injection
the muscle activation patterns of the patients move
toward a normal activation pattern, as expressed in
higher adductor Activation Ratio’s and near normal
Principal Action directions [5,51].
Main outcome parameters: Muscle specific Principal
Action (PA) parameters and muscle specific Activation
Ratios (AR) before and after a subacromial injection
with lidocaïne.
Model simulation (H)
Impaired cuff function and RoM data obtained from the
3D-Kinematics measurements will be used as input data
for the inverse dynamic model simulation with the Delft
Shoulder and Elbow Model (DSEM) in order to estimate
discrete muscle forces and joint reaction forces with the
use of inverse dynamic simulation [64]. Muscle quality
and glenohumeral joint stability can be varied and com-
pared to the observations on muscle quality (MRI) and
proximal migration (2D radiography) [57].
Figure 3 Experimental setup for isometric arm-shoulder force
tasks in 24 directions. The subject has the arm in a splint, which
is connected to a force transducer. Subjects must bring the arm
force driven red cursor into the blue target area, which indicates
force direction (n = 24 directions) and force magnitude. The exerted
force, perpendicular to the humerus long axis, is recorded together
with EMG to measure the activity of 10 individual shoulder muscles.
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outcomes, we expect to find coactivation of arm adduc-
tors on affected shoulders during arm abduction simula-
tions, in combination with altered shoulder muscle force
patterns for standardized movements with respect to the
control shoulders.
The predicted model muscle forces can be used for
validation and interpretation of recorded muscle activa-
tions by means of EMG.
Patient phenotyping (I)
The radiological and biomechanical outcome measures
will be related to patients’ clinical status or phenotype.
We combine an overall general health outcome measure
( i , e ,S F 3 6 ) ,ar e g i o n a l( e . g .s houlder) outcome measure,
and a disease- or condition-specific measure for patient
assessment [65].
- SF-36: Questionnaire to measure quality of life,
based on physical function, illness, pain and mental
health [66].
- Illness Perception Questionnaire (IPQ): measures
perception and impact of Illness [67].
- The Disabilities of the Arm, Shoulder and Hand
(DASH) score: to quantify impact and functional
impairment of shoulder arm and hand function [68].
- Constant Shoulder Score (CS): used by physicians
to quantify the severity of symptoms and functional
impairment in affected shoulders, compared to the
unaffected shoulder [69].
- Western Ontario Rotator Cuff index (WORC): a
self-reported outcome measure for assessing
shoulder problems as a consequence of rotator cuff
disease [70].
- Visual Analogue Scale (VAS) for pain during daily
life activities and in rest.
Relate outcome measures to pathophysiological
mechanisms
Results of the recorded clinical, radiological and biome-
chanical measurements will be interpreted and combined
in order to classify patients in to the hypothesized etiologi-
cal subgroups (Figure 4). Ultimately, if a patient has evi-
dence of co-activation of arm depressors with abduction
but no signs of shape parameters (e.g. acromion classifica-
tion) playing a role, this would implicate that an intrinsic
and dynamic mechanism is the main pathologic mechan-
ism. On the other hand, evidence of e.g. a type III acro-
mion (hooked) without any signs of relative cranial
translation of the humerus would be suggestive of a pri-
marily extrinsic and static/structural cause.
The following scenarios are considered:
1) Dynamically reduced subacromial space, due to
(relative) cranial translation of the humerus.
Humerus cranialisation causing encroachment of sub-
acromial tissues will be characterized by limited AH in
resting state on standard radiographs, further decrease
in AH during abduction tasks, and decreased recon-
structed subacromial volume (MRI). In some patients,
this cranialisation might be (partially) compensated by
I) co-activation of arm adductor muscles, and/or II)
altered kinematics of the humerus and the scapula
(scapulohumoral rhythm). Nevertheless, instead of a
compensation mechanism, altered scapulohumeral
r h y t h mc a na l s ob eac a u s eo fS I Si ns o m ep a t i e n t s
(e.g. decreased scapula lateral rotation during arm
abduction, with consequent relative cranial translation
of the humerus). Pain is suspected to be the main trig-
ger for compensation mechanisms. Therefore, we
expect that these compensation mechanisms will be
Figure 4 Schematic outline for relating outcome measures to pathophysiological mechanisms. We expect to identify one or more of the
hypothesized etiological mechanisms in each SIS patient. These mechanisms might be related to the reported variations in SIS symptoms,
course, and treatment outcome. (MRI = Magnetic Resonance Imaging, X-ray & EMG task = radiographs during EMG recorded abduction and
adduction tasks for measurements of acromiohumeral distance, and FoB = 3D kinematics with Flock of Birds system).
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after a subacromial injection with lidocaine.
Particularly relevant positive outcome measures for
this subgroup are: decreased AH, low AR (adductor
co-activation), altered Principal Action for adductor
muscles, decreased reconstructed subacromial
volume during active abduction, degeneration of
rotator cuff muscles and altered scapulohumeral
rhythm.
2a) Statically reduced subacromial space, due to
structural narrowing (classic etiology). The subacro-
mial space can be narrowed as a consequence of
structural anatomic variations, e.g. a hooked acro-
mion impinging on the subacromial tissues. These
potential causes will be investigated and quantified
using shoulder radiographs and (segmented) MRI-
arthrographies.
As a consequence of structures impinging on the
rotator cuff, compensation mechanisms might be
present to prevent further subacromial encroach-
ment, including altered scapulohumeral rhythm
(increased lateral rotation or increased posterior tilt
during arm abduction) and adductor co-activation
during arm abduction. Again, we expect that these
compensations mechanisms will be less manifest
after a subacromial injection with lidocaine.
Important outcome measures for this subgroup are:
shape parameters of scapula (hooked acromion,
Bigliani classification, acromial spurs) and humerus,
the presence and extend of rotator cuff tendinosis
(fibrosis, tendinitis, partial articular or bursal side
tear).
2b) Statically reduced subacromial space, as a conse-
quence of subacromial inflammatory processes, with-
out signs of actual structural subacromial narrowing.
In some subjects, symptoms of SIS are related to pre-
dominantly intrinsic causes. In these patients, we
expect to find little or no anatomic variations imping-
ing on the cuff and no evidently decreased AH. The
hypothesized disbalance between subacromial volume
and the space needed for subacromial structures can
be caused by e.g. subacromial oedema, fibrosis, tendi-
nosis and tendinitis, which will be mainly assessed by
means of MRI.
As a consequence of the subacromial inflammatory
reaction and pain, patients might have an altered sca-
pulohumeral rhythm and adductor co-activation.
Main outcome measures for characterizing this sub-
group are: the presence and extend of rotator cuff
tendinosis (fibrosis, tendinitis, partial articular or
bursal side tear) and subacromial oedema.
2c) Statically reduced subacromial space due to
encroachment of subacromial tissues by an adjoining
pathology or other structures than the acromion.
Besides humerus cranialisation and the classical
etiologic mechanisms that have been related to SIS,
subacromial tissues can be impinged as a conse-
quence of an adjoining pathology or other struc-
tures than the acromion. For example, coracoid
impingement and subacromial osteophytes in
(otherwise asymptomatic) osteoarthritis of the acro-
mioclavicular (AC)-joint have been reported as
causes for pain with arm abduction. In our study,
these causes will be investigated with the use of
radiographs, MRI and 3D-kinematics recordings.
Therefore, the most important methods of investi-
gation for this subgroup are: MRI and radiographs
to evaluate e.g. AC-osteoarthritis and subacromial
osteophytes, impingement on the superior aspect of
the glenoid, impingement at the outlet of the
shoulder, coracoid impingement, and other (suba-
cromial) pathologies or impinging structures caus-
ing a deficiency of subacromial space.
3) Combination groups
As with many diagnoses in general, the cause of SIS
symptoms is presumably heterogeneous. We expect
that in most patients one of the hypothesized mechan-
isms will play a main role, but in a subgroup of
patients, a combination of 2 or more mechanisms will
be causing SIS.
Additionally, we expect to identify specific pathologies
other than SIS causing shoulder complaints, including cuff
tears, calcifying tendinitis, first stage frozen shoulder, and
SLAP lesions. Patients with these pathologies will not be
included in the current SISTIM study, but some (cuff
tears or calcifying tendinitis) will be analyzed separately in
distinct research projects (trial registry numbers:
NTR1545 and NTR2282).
Statistical analyses
Patient data, including patient characteristics, physical
examination, interview, radiological findings, question-
naires, psychological scores, biomechanical measure-
ments and MRI findings will be entered in a database.
With regards to presence of cranial translation of the
humerus as detected on radiographs during rest and
abduction and adduction tasks, statistical analysis will be
performed by a means of repeated measures ANOVA,
with the measure of co-contraction controlled as a con-
founding factor.
For the isometric Principal Action EMG measure-
ments, data are tested by means of a General Linear
Model analysis for repeated measures, controlling for
factors Muscle, subacromial anaesthetics, sAH and VAS
for pain.
RoM in standardized motions will be analyzed with a
General Linear Model analysis for repeated measures, con-
trolling for factors VAS pain, subacromial anaesthetic,
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analyzed equally.
Additionally, we will use students’ unpaired t-tests to
compare continuous variables (e.g. patient characteris-
tics, clinical scores, RoM, dAH) between defined patho-
logic subgroups.
Discussion
Despite the fact that there is no clear consensus on its
etiologic mechanisms nor which combination of diag-
nostic criteria defines SIS, numerous clinical trials exist
on patients with the diagnostic label “SIS”.C o n f l i c t i n g
in- and exclusion criteria for SIS are used across these
heterogeneous studies, complicating interpretation of
reported results. Additionally, several pathologies that
have a similar patient history, pain pattern and findings
on physical examination can be mistakenly diagnosed as
SIS [45]. Conclusions of these studies are based on
results of patients with varying etiologic mechanisms
and for that matter even varying pathologies wrongly
diagnosed as SIS, resulting in the wide variety on views
with respect to aetiology, diagnosis and treatment of SIS
that exists nowadays. Instead of studying the outcomes
of various treatment modalities in patients with SIS
symptoms, first a detailed analysis of possible underlying
pathophysiologic mechanisms is needed. In this way,
potential subgroups can be identified, subsequently
needing specific approaches in both research and clinical
decision-making, with regards to diagnostics and treat-
ment pathways.
The SISTIM study is a cross-sectional descriptive large
cohort study in which consecutively included patients
will undergo a multitude of biomechanical, kinematical
and clinical tests. Patients will be selected using strict
eligibility criteria, including radiographs and MRI. As a
result a unique set of radiological (radiographs com-
bined with EMG, MRI), biomechanical (muscle activa-
tion patterns) and 3D motion data (Flock of Birds) will
be available on each individual patient, besides usual
clinical data and outcome measures (e.g. CS, WORC).
This will give better insight in the etiologic mechanisms
in patients with symptoms diagnosed as SIS. Whether
there is actual encroachment of subacromial tissues is
determined by 1) the volume of these tissues and 2) the
available subacromial space (static and dynamic). Both
are investigated in our study: the status of subacromial
tissues will be investigated with MRI, and we will use
bony shape parameters, 3D kinematics and muscle acti-
vation patterns, to study their role on the subacromial
volume of each patient. As this subacromial space is
mainly limited by the scapula and humerus, the interac-
tion of (bony) shape parameters and the (dynamic) posi-
tion of these structures will be investigated as well.
Our ultimate goal would be to design clinically applic-
able instruments for differentiating between patients
that might benefit from a specific treatment modality (e.
g. acromionplasty, depressor training etc.). Therefore,
we plan to use our developed experimental methods
and classification systems in a subsequent clinical trial,
for assessing treatment outcomes of standard care meth-
ods in discrete etiological subgroups.
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